Hypothesis: Iron chelation plays a vital role in neutrophilic inflammation

BioMetals

Volumn 10, Issue 2, 1997, Pages 135-142

  Ghio, Andrew J ^a   Piantadosi, Claude A ^b   Crumbliss, Alvin L ^c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Free radicals; Inflammation; Iron; Iron chelates; Neutrophils

Indexed keywords

CHELATING AGENT; CYTOKINE; FERRIC ION; FERRITIN; FERROUS ION; GLYCOPROTEIN; ICOSANOID; IRON CHELATE; LACTOFERRIN; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CANCER; FIBROSIS; HUMAN; HUMAN CELL; HYPOTHESIS; INFLAMMATION; IRON CHELATION; MACROPHAGE; MINERALIZATION; NEUTROPHIL; OXIDATION REDUCTION STATE; PHAGOCYTE; RETICULOENDOTHELIAL SYSTEM; TISSUE INJURY;

EID: 0030899998     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018387308517     Document Type: Article

References (89)

1. Affres H, Perez J, Hagege J, et al. 1991 Desferrioxamine regulates tumor necrosis factor release in mesangial cells. Kidney International 19, 822-830.
2. Ames BN. 1983 Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221, 1256-1264.
3. Anghileri LJ. 1992 Soft tissue calcification induced by iron complexes. Calcif Tissue Int 51, 83-84.
4. Arnold RR, Brewer M, Gauthier JJ. 1980 Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 28, 893-898.
5. 2 synthesis and lipoxygenase activity. FEBS Lett 245, 105-109.
6. Bellavite P. 1988 The superoxide-forming enzymatic system of phagocytes. Free Radic Biol Med 4, 225-261.
7. Bharadwaj M, Khanna N, Mathur A, Chaturvedi UC. 1991 Effect of macrophage-derived factor on hypoferraemia induced by Japanese encephalitis virus in mice. Clin Exp Immunol 83, 215-218.
8. Bienfait HF, Bino RJ, van der Blick AM, Duivenvoorden JF, Fontaine JM. 1983 Characterization of ferric reducing activity in roots of Fe-deficient Phaseolus vulgaris. Physiol Plant 59, 196-202.
9. Birgegard G, Caro J. 1984 Increased ferritin synthesis and iron uptake in inflammatory mouse macrophages. Scand J Haemotol 33, 43-48.
10. Birgens HS. 1991 The interaction of lactoferrin with human macrophages. Danish Medical Bulletin 38, 244-252.
11. Birgens HS, Kristensen LO, Borregaard N, Karle H, Hansen NE. 1988 Lactoferrin-mediated transfer of iron to intracellular ferritin in human monocytes. Eur J Haematol 41, 52-57.
12. Boivin G. 1975 Cutaneous calcinosis induced by topical calciphylaxis in rats. Ultrastructural aspects. Archives D Anatomie Microscopique Et De Morphologie Experimentale 64, 183-205.
13. Bortner CA, Miller RD, Arnold RR. 1986 Bactericidal effect of lactoferrin on Legionella pneumophila. Infect Immun 51, 373-377.
14. Britigan BE, Hassett DJ, Rosen GM, Hamill DR, Cohen MS. 1989 Neutrophil degranulation inhibits potential hydroxyl-radical formation. Relative impact of myeloperoxidase and lactoferrin release on hydroxyl-radical production by iron-supplemented neutrophils assessed by spin-trapping techiques. Biochem J 264, 447-455.
15. Britigan BE, Roeder TL, Rasmussen GT, et al. 1992 Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generated hydroxyl radical and causes synergistic damage to endothelial cells. J Clin Invest 90, 2187-2196.
16. Bullen JJ. 1987 Iron and the antibacterial function of polymorphonuclear leucocytes. In: Bullen JJ, Griffiths E, eds. Iron and Infection. New York: John Wiley and Sons Ltd.: 211-241.
17. Bullen JJ, Armstrong JA. 1979 The role of lactoferrin in the bactericidal function of polymorphonuclear leukocytes. Immunology 36, 781-791.
18. Bullen JJ, Ward CG, Wallis SN. 1974 Virulence and the role of iron in Pseudomonas aeruginosa infection. Infect Immun 10, 443-450.
19. Burger RM, Peisach J, Horwitz SB. 1981 Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem 256, 11636-11644.
20. Cartwright GE, Lee GR. 1971 The anemia in chronic disorders. Br J Haematol 21, 147-151.
21. Cerutti PA. 1985 Prooxidant states and tumor promotion. Science 227, 375-381.
22. Chandler DB, Barton JC, Briggs DD, et al. 1988 Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster. Am Rev Respir Dis 137, 85-89.
23. Crichton RR, Charloteaux-Wauters M. 1987 Iron transport and storage. Europ J Biochem 164, 485-506.
24. Crichton RR, Ward RJ, 1995 Iron species in iron homeostasis and toxicity. Analyst 120, 693-697.
25. Cross JH. 1984 The relationship of plasmid-mediated iron transport and bacterial virulence. Annu Rev Microbiol 38, 69-89.
26. Cruickshank AH, McConnell ME, Miller DG. 1963 Malignancy in scars, chronic ulcers and sinuses. J Clin Pathol 16, 573-580.
27. Dancis A, Roman DG, Anderson GJ, Hinnebusch AG, Klausner RD. 1992 Ferric reductase of Saccharomyces cerevisiae: molecular characterization, role in iron uptake, and transcriptional control by iron. Proc Natl Acad Sci USA 89, 3869-3873.
28. de Martino M, Rossi ME, Resti M, Vullo C, Vierucci A. 1984 Changes in superoxide anion production in neutrophils from multitransfused beta-thalassemia patients: correlation with ferritin levels and liver damage. Acta Haemat 71, 289-298.
29. Denny JJ, Robson WD, Irwin DA. 1937 The prevention of silicosis by metallic aluminum. Canadian Medical Association Journal 37, 11-17.
30. de Vet BJCM, ten Hoopen CH. 1978 Lactoferrin in human neutrophilic polymorphonuclear leukocytes in relation to iron metabolism. Acta Med Scand 203, 197-203.
31. Domingue PAG, Lambert PA, Brown MRW. 1989 Iron depletion alters surface-associated properties of Staphylococcus aureus and its association to human neutrophils in chemiluminescence. FEMS Microbiol Lett 59, 265-268.
32. Dubois F, Begin R, Cantin A, et al. 1988 Aluminum inhalation reduces silicosis in a sheep model. Am Rev Respir Dis 137, 1172-1179.
33. Foster BJ, Clagett-Carr K, Hoth D, Leyland-Jones B. 1986 The second metal with clinical activity. Cancer Treat Rep 70, 1311-1319.
34. Franklin TJ, Hales NJ, Johnstone D, et al. 1991 Approaches to the design of anti-fibrotic drugs. Biochem Soc Trans 19, 812-815.
35. Gardiner IT, Uff JS. 1978 "Blue bodies" in a case of cryptogenic fibrosing alveolitis (desquamative type) - an ultra-structural study. Thorax 33, 806-813.
36. Geesin JC, Hendricks LJ, Falkenstein PA, Gordon JS, Berg RA. 1991 Regulation of collagen synthesis by ascorbic acid: Characterization of the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys 290, 127-132.
37. Giri SN, Misra HP, Chandler DB, Chen Z. 1983 Increases in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters. Exp Mol Pathol 39, 317-326.
38. Graf E, Eaton JW. 1985 Dietary suppression of colonic cancer. Cancer 56, 717-718.
39. Hann HL, Stahlhut MW, Blumberg BS. 1988 Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res 48, 4168-4170.
40. Hann HL, Stahlhut MW, Menduke H. 1991 Iron enhances tumor growth. Observations on spontaneous mammary tumors in mice. Cancer 68, 2407-2410.
41. Hunt J, Richards RJ, Harwood R, Jacobs A. 1979 The effect of desferrioxamine on fibroblasts and collagen formation in cell cultures. Br J Haematol 41, 69-76.
42. Hutchinson F. 1985 Chemical changes induced in DNA by ionizing radiation. Progr Nucl Acid Res Mol Biol 32, 115-154.
43. Hutton JJ, Tappel AL, Udenfriend S. 1967 Cofactor and substrate requirements of collagen proline hydroxylase. Arch Biochem Biophys 118, 231-240.
44. Iancu TC. 1989 Iron and neoplasia: ferritin and hemosiderin in tumor cells. Ultrastruct Pathol 13, 573-584.
45. Imlay JA, Linn S. 1988 DNA damage and oxygen radical toxicity. Science 240, 1302-1309.
46. Jacobs A, Slater A, Whittaker JA, Canellos G, Wiernik PH, 1976a Serum ferritin concentrations in untreated Hodgkin's disease. Br J Cancer 34, 162-166.
47. Jacobs A, Jones B, Ricketts C, Bulbrook RD, Wang DY. 1976b Serum ferritin concentrations in early breast cancer. Br J Cancer 34, 286-289.
48. Jesaitis AJ, Buescher ES, Harrison D, et al. 1990 Ultrastructural localization of cytochrome b in the membranes of resting and phagocytosing human granulocytes. J Clin Invest 85, 821-835.
49. Jones GJ, Palenik BP, Morel FMM. 1987 Trace metal reduction by phytoplankton: the role of plasmalemma redox enzymes. J Phycol 23, 237-244.
50. Kennedy JI, Chandler DB, Jackson RM, Fulmer JD. 1986 Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent. Chest 89, 123s-125s.
51. Konijn AM, Hershko C. 1977 Ferritin synthesis in inflammation. Pathogenesis of impaired iron release. Br J Haematol 37, 7-16.
52. Koss MN, Johnson FB, Hoschholzer L. 1981 Pulmonary blue bodies. Human Pathol 12, 258-266.
53. Leffell MS, Sptiznagel JK. 1975 Fate of human lactoferrin and myeloperoxidase in phagocytizing human neutrophils: effects of immunoglobulin G subclasses and immune complexes coated on latex beads. Infect Immun 12, 813-820.
54. Lewis MS, Whatley RE, Cain P, et al. 1988 Hydrogen peroxide stimulates the synthesis of platelethyactivating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 82, 2045-2055.
55. Lipschitz DA, Cook JD, Finch CA. 1974 A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290, 1213-1216.
56. Lugano EM, Dauber JH, Daniele RP. 1982 Acute experimental silicosis. Lung morphology, histology, and macrophage chemotaxin secretion. Am J Pathol 109, 27-36.
57. Markowetz B, van Snick JI, Masson PL. 1979 Binding and ingestion of human lactoferrin by mouse alveolar macrophages. Thorax 34, 209-212.
58. Mason AZ, Nott JA. 1981 The role of intracellular biomineralized granules in the regulation and detoxification of metals in gastropods with special reference to the marine prosobranch Littorina littorea. Aquatic Toxicology 1, 239-256.
59. Matzner Y, Konijn AM, Hershko C. 1980 Serum ferritin in hematological malignancies. Am J Hematol 9, 13-22.
60. Molloy AL, Winterbourn CC. 1990 Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin. Blood 75, 985-989.
61. Neilands JB. 1981 Iron absorption and transport in microorganisms. Annu Rev Nutr 1, 27-46.
62. Olakanmi O, McGowan SE, Hayek MB, Britigan BE. 1993 Iron sequestration by macrophages decreases the potential for extracellular hydroxyl radical formation. J Clin Invest 91, 889-899.
63. Pankalainen M, Kivirikko KI. 1971 The absence of iron and certain coenzymes in highly purified protocollagen proline hydroxylase. Biochim Biophys Acta 229, 504-508.
64. Parry DH, Worwood M, Jacobs A. 1975 Serum ferritin in acute leukemia at presentation and during remission. Br Med Bull 1, 245-249.
65. Patel AR, Shah PC, Vohra RM, Hart WL, Shah JR. 1980 Serum ferritin levels in hematological malignant neoplasms. Arch Pathol Lab Med 104, 509-512.
66. Penneys NS, Zlatkiss I. 1990 Immunohistochemical demonstration of ferritin in sweat gland and sweat gland neoplasms. J Cutan Pathol 17, 32-36.
67. Prockop DJ. 1971 Role of iron in the synthesis of collagen in connective tissue. Fed Proc 30, 984-990.
68. Putcha L, Griffith DP, Feldman S. 1985 Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi. Eur J Clin Pharmacol 28, 439-445.
69. Raica M. 1990 Calciphylaxis induced by iron-citrate sorbitol. Exp Pathol 38, 196-200.
70. Rausch WD, Hirata Y, Nagatsu T, Riederer P, Jellinger K. 1988 Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effect of iron and phosphorylating agents. J Neurochem 50, 202-208.
71. 91-phox subunit of the human NADPH phagocyte oxidoreductase. Molecular and Cellular Biology 13, 4342-4350.
72. 2 forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta 853, 65-89.
73. Schapira RM, Ghio AJ, Effros RM, et al. 1995 Hydroxyl radical production and injury in the rat lung following silica or titanium dioxide instillation. Am J Respir Cell Mol Biol 12, 220-226.
74. Sijmons PC, van den Briel W, Bienfait HF. 1984 Cytosolic NADPH is the electron donor for extracellular Fe III reduction in iron-deficient bean roots. Plant Physiol 75, 219-221.
75. Simeonova PP, Luster MI. 1995 Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages. Am J Respir Cell Mol Biol 12, 676-683.
76. Simkiss K. 1977 Biomineralization and detoxification. Calcif Tiss Res 24, 199-200.
77. Soriano F, Ponte C, Santamaria M, Fernandez-Roblas R. 1987 Struvite crystal formation by Corynebacterium group D2 in human urine and its prevention by acetohydroxamic acid. Eur Urol 13, 271-273.
78. Tabor E, Kim CM. 1991 Inhibition of human hepatocellular carcinoma and hepatoblastoma cell lines by deferoxamine. J Med Virol 34, 45-50.
79. Torti SV, Torti FM. 1994 Iron and ferritin in inflammation and cancer. Adv Inorg Biochem 10, 119-137.
80. van Snick JL, Masson PL, Heremans JF. 1974 The involvement of lactoferrin in the hyposiderernia of acute inflammation. J Exp Med 140, 1068-1084.
81. van Snick J, Masson PL, Heremans JF. 1975 The affinity of lactoferrin for the reticulo-endothelial system (RES) as the molecular basis for the hyposideraemia of inflammation. In: Crichton RR, ed. Proteins of Iron Storage and Transport in Biochemistry and Medicine. Amsterdam: North Holland Publishing Company; 433-438.
82. th component of human complement directs oxygen radical-mediated conversion to specific sites and causes nonenzymatic activation. Complement Inflamm 8, 313-319.
83. Wahren B, Alpert E, Eposti P. 1977 Multiple antigens as marker substances in germinal tumors or the testis. JNCI 58, 489-493.
84. Weinbren K, Saim R, Greenberg G. 1978 Intramuscular injections of iron compounds and oncogenesis in man. Br Med J 1, 683-685.
85. White DA, Kris MG, Stover DE. 1987 Bronchoalveolar lavage cell populations in bleomycin lung toxicity. Thorax 42, 551-552.
86. Williams JJ, Rodman JS, Peterson CM. 1984 A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 311, 760-764.
87. Wright AC, Simpson LM, Oliver JD. 1981 Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun 34, 503-507.
88. Zandman-Goddard G, Matzner Y, Konijn AM, Hershko C. 1986 Cerebrospinal fluid ferritin in malignant CNS involvement. Cancer 58, 1346-1349.
89. Zhou X, DeTolla L, Custer RP, London WT. 1987 Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma. Cancer 59, 1430-1437.